Status:
COMPLETED
Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Conditions:
Cholelithiases
Appendicitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Lignocaine is a local anaesthetic that is widely used in all medical and surgical fields. Many clinical studies have shown that intravenous (IV) lignocaine given in the perioperative period was safe, ...
Detailed Description
All volunteers will be randomly assigned into two groups based on computer generated randomisation tables. Group Lignocaine will receive an IV bolus dose of 1.5 mg/kg of 2% lignocaine HCL diluted up ...
Eligibility Criteria
Inclusion
- American Society of Anaesthesiology (ASA) I or II patients.
- Patients aged between 18-75 years of age.
- Patients scheduled for elective laparoscopic cholecystectomy.
- Patients scheduled for laparoscopic hernioplasty.
- Patients scheduled for emergency laparoscopic appendicectomy.
- Patients scheduled for emergency laparoscopic cystectomy.
- Patient weight ranging from 50 - 100 kg.
- Surgery lasting at least one hour.
Exclusion
- Patients with a known allergy to study drug.
- Patients with body mass index (BMI) more than 35 kg m-2.
- Patients who are taking sedatives.
- Patients with chronic substance abuse.
Key Trial Info
Start Date :
January 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2021
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06064331
Start Date
January 21 2021
End Date
November 19 2021
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusat Perubatan Universiti Kebangsaan Malaysia
Kuala Lumpur, Kuala Lumpur, Malaysia, 56000